Showing results (51-60 of 102) with videos related to
Sort By:
Pageof 11
Nature Communications|March 30, 2024
Identification of spatially-resolved markers of malignant transformation in Intraductal Papillary Mucinous NeoplasmsAntonio Agostini, Geny Piro, Frediano Inzani, et al.Scientific Reports|May 10, 2018
Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinomaMichele Simbolo, Caterina Vicentini, Andrea Ruzzenente, et al.British Journal of Cancer|November 17, 2022
CXCR1/2 dual-inhibitor ladarixin reduces tumour burden and promotes immunotherapy response in pancreatic cancerGeny Piro, Carmine Carbone, Antonio Agostini, et al.Scientific Reports|June 25, 2021
Molecular alterations in basal cell carcinoma subtypesLucia Di Nardo, Cristina Pellegrini, Alessandro Di Stefani, et al.Frontiers in Cell and Developmental Biology|May 16, 2020
Organoid-Transplant Model Systems to Study the Effects of Obesity on the Pancreatic Carcinogenesis in vivoFrancesca Lupo, Geny Piro, Lorena Torroni, et al.Journal of Experimental & Clinical Cancer Research : CR|April 24, 2025
A first-in-class inhibitor of homologous recombination DNA repair counteracts tumour growth, metastasis and therapeutic resistance in pancreatic cancerJuliana Calheiros, Rita Silva, Filipa Barbosa, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 16, 2019
Gene Expression Profiling of Lung Atypical Carcinoids and Large Cell Neuroendocrine Carcinomas Identifies Three Transcriptomic Subtypes with Specific Genomic AlterationsMichele Simbolo, Stefano Barbi, Matteo Fassan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2021
Homologous Recombination Deficiency in Pancreatic Cancer: A Systematic Review and Prevalence Meta-AnalysisRaffaella Casolino, Salvatore Paiella, Danila Azzolina, et al.Cancer Research|January 22, 2025
SMAD4 and KRAS Status Shapes Cancer Cell-Stromal Cross-Talk and Therapeutic Response in Pancreatic CancerEloise G Lloyd, Muntadher Jihad, Judhell S Manansala, et al.Pharmacological Research|February 21, 2026
Tumor-specific targeting of a mitochondrial Kv1.3 channel inhibitor through conjugation to gastrin/cholecystokinin B receptor ligand strongly reduces pancreatic ductal adenocarcinoma in orthotopic modelsSofia Parrasia, Carlotta Paoli, Tatiana Varanita, et al.Pageof 11